O. I. Epstein

1.4k total citations
108 papers, 855 citations indexed

About

O. I. Epstein is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, O. I. Epstein has authored 108 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 28 papers in Physiology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in O. I. Epstein's work include S100 Proteins and Annexins (21 papers), Chemical and Physical Studies (14 papers) and Neuroscience and Neuropharmacology Research (10 papers). O. I. Epstein is often cited by papers focused on S100 Proteins and Annexins (21 papers), Chemical and Physical Studies (14 papers) and Neuroscience and Neuropharmacology Research (10 papers). O. I. Epstein collaborates with scholars based in Russia, United States and United Kingdom. O. I. Epstein's co-authors include С. А. Тарасов, М. Б. Штарк, С. А. Сергеева, Alan C. Cheng, Paul H. Wen, Thomas A. Dineen, Vladimir O. Pustylnyak, Douglas A. Whittington, Dean Hickman and Robert T. Fremeau and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Brain Research.

In The Last Decade

O. I. Epstein

95 papers receiving 756 citations

Peers

O. I. Epstein
Varsha G. Desai United States
Rabia Sarroukh Belgium
Francesco Misiti Italy
Wenyong Xiong China
Rosamaria Fiorini Italy
Kristin M. Rusche United States
Martin L. Meltz United States
Ali Haeri Rohani Iran
Hsien C. Cheng United States
В.Л. Воейков Russia
Varsha G. Desai United States
O. I. Epstein
Citations per year, relative to O. I. Epstein O. I. Epstein (= 1×) peers Varsha G. Desai

Countries citing papers authored by O. I. Epstein

Since Specialization
Citations

This map shows the geographic impact of O. I. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. I. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. I. Epstein more than expected).

Fields of papers citing papers by O. I. Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. I. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. I. Epstein. The network helps show where O. I. Epstein may publish in the future.

Co-authorship network of co-authors of O. I. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of O. I. Epstein. A scholar is included among the top collaborators of O. I. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. I. Epstein. O. I. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Петрова, Н. В., et al.. (2022). Therapeutic potential of highly diluted antibodies in antibiotic-resistant infection. European Journal of Pharmaceutical Sciences. 173. 106161–106161. 7 indexed citations
2.
Парфенов, В. А., et al.. (2019). <p>Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments</p>. Neuropsychiatric Disease and Treatment. Volume 15. 1381–1402. 38 indexed citations
3.
4.
Epstein, O. I., et al.. (2016). Antiamnesic effects divaza and its component model β-amyloid amnesia. S S Korsakov Journal of Neurology and Psychiatry. 116(9). 69–69. 5 indexed citations
5.
Тарасов, С. А., et al.. (2015). In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form. Neuropsychiatric Disease and Treatment. 11. 2837–2837. 8 indexed citations
6.
Тарасов, С. А., et al.. (2013). Subetta Treatment Increases Adiponectin Secretion by Mature Human AdipocytesIn Vitro. International Journal of Endocrinology. 2013. 1–4. 20 indexed citations
7.
Veselovskaya, Elizaveta, et al.. (2013). Experimental Study on the Efficacy of the Drug Brizantin in the Model of Nicotine Dependence. Bulletin of Experimental Biology and Medicine. 154(3). 339–342. 1 indexed citations
8.
Бугаева, Л. И., et al.. (2012). Experimental Study of the Effects of Dietressa, a New Weight-Reducing Drug. Bulletin of Experimental Biology and Medicine. 152(3). 321–324.
9.
Epstein, O. I.. (2012). Release-Activity: A Long Way from Phenomenon to New Drugs. Bulletin of Experimental Biology and Medicine. 154(1). 54–58. 13 indexed citations
10.
Epstein, O. I., А. М. Дыгай, С. А. Сергеева, et al.. (2009). Experimental Study of Ultralow-Dose Antibodies to Cyclophosphamide on Cyclophosphamide Myelotoxicity. Bulletin of Experimental Biology and Medicine. 147(3). 323–327.
11.
Epstein, O. I., et al.. (2009). Antibodies to calcium-binding S100B protein block the conditioning of long-term sensitization in the terrestrial snail. Pharmacology Biochemistry and Behavior. 94(1). 37–42. 4 indexed citations
12.
Epstein, O. I., et al.. (2007). Psychotropic drug tenoten activates mitogen-activated MAP/ERK kinase regulatory cascade controlling the neuroprotective effects. Bulletin of Experimental Biology and Medicine. 144(3). 319–321. 1 indexed citations
13.
Воронина, Т. А., et al.. (2007). Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein. Bulletin of Experimental Biology and Medicine. 143(5). 598–600. 5 indexed citations
14.
Сергеева, С. А., et al.. (2007). Comparison of the cardioprotective effects of cardos and losartan in rats with experimental chronic cardiac insufficiency. Bulletin of Experimental Biology and Medicine. 143(4). 434–436. 1 indexed citations
15.
Воронина, Т. А., et al.. (2005). Neuroprotective Activity of Proproten in Rats with Experimental Local Photothrombosis of the Prefrontal Cortex. Bulletin of Experimental Biology and Medicine. 139(4). 404–407. 2 indexed citations
16.
Epstein, O. I., G. N. Zyuz’kov, Л. А. Ставрова, et al.. (2005). Mechanisms of Hepatoprotective Effect of Preparation Containing Superlow Doses of Antibodies to Granulocytic Colony-Stimulating Factor. Bulletin of Experimental Biology and Medicine. 140(5). 598–602. 11 indexed citations
17.
Epstein, O. I., et al.. (2004). Dose-Dependent Effects and Specificity of Action of Antibodies to Endogenous Regulators in Ultralow Doses. Bulletin of Experimental Biology and Medicine. 137(5). 460–462. 4 indexed citations
18.
Сергеева, С. А., et al.. (2003). Clinical Efficiency of Epigam in Patients with Exacerbation of Peptic Ulcer Disease of the Stomach and Duodenum. Bulletin of Experimental Biology and Medicine. 135(S7). 159–162. 2 indexed citations
19.
Epstein, O. I., et al.. (2003). Behavioral Effects of Potentiated Antibodies to Morphine and μ-Opioid Receptors during Withdrawal Syndrome. Bulletin of Experimental Biology and Medicine. 135(S7). 29–31. 1 indexed citations
20.
Ivanova, Svetlana А., et al.. (2003). Changes in Immunological Parameters in Patients with Opium Abuse Receiving ANAR Therapy. Bulletin of Experimental Biology and Medicine. 135(S7). 189–191. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Varsha G. Desai Breakdown of academic impact, for papers by Rabia Sarroukh Breakdown of academic impact, for papers by Francesco Misiti Breakdown of academic impact, for papers by Wenyong Xiong Breakdown of academic impact, for papers by Rosamaria Fiorini Breakdown of academic impact, for papers by Kristin M. Rusche Breakdown of academic impact, for papers by Martin L. Meltz Breakdown of academic impact, for papers by Ali Haeri Rohani Breakdown of academic impact, for papers by Hsien C. Cheng Breakdown of academic impact, for papers by В.Л. Воейков
Rankless by CCL
2026